Azitra, Inc. (AZTR)

↓ Download CSV

CIK 0001701478 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Azitra, Inc. reported revenue of $0, down 100.0% from the prior year. The company ran a net loss. It held $5.03M in total assets against $1.22M in total liabilities.

Key ratios (FY2025)

-288.2%
Return on equity
-100.0%
Revenue growth (YoY)
Metric (FY)20252024202320222021
Revenue$0$7.5K$686.0K$284.0K
Operating Income-$10.97M-$10.99M-$7.45M-$9.45M
Net Income-$10.96M-$8.97M-$11.28M-$10.68M
EPS (Diluted)$-2.25$-15.70$-54.98$-12.74
Total Assets$5.03M$7.36M$5.12M$7.17M
Total Liabilities$1.22M$1.66M$2.20M$9.73M
Shareholders' Equity$3.80M$5.70M$2.91M-$36.26M-$25.77M
Cash & Equivalents$2.07M$4.55M$1.80M$3.49M
Operating Cash Flow-$11.22M-$10.18M-$7.36M-$8.35M
Capital Expenditures$24.2K$8.6K$26.5K$33.1K
Shares Outstanding10.74M1.15M403.2K1.04M